Stock Report

All about this stock under one free report Last Updated: 01-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

Serious stock insights. No fluff. No FOMO.

Recently Viewed

Clear All

Mesco Pharmaceuticals Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: MESCOPHARM | BSE: 500274

₹4.54

up-down-arrow ₹0.21 (4.85%)

As on 10-Jan-2022IST

Market cap

info icon

₹9 Cr

Revenue (TTM)

info icon

₹0 Cr

P/E Ratio

info icon

--

P/B Ratio

info icon

-0.9

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -- -- --
EBIT 0.00 0.00 -25.00 25.73 12.74
Net Profit 0.00 0.00 -25.00 25.73 -224.57
EPS 0.00 0.00 -25.00 25.74 -216.72
Book Value -- -- -0.04 -1.65 -1.75
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsTTMMar-21Mar-20
EBIT-Margin info ----------
Net Margin info ----------
Return on equity info 0.000.00--0.000.00
Return on Capital info -74.68-73.78---2.08-45.82
Return on Assets info -69.76-69.80-2.49-1.99-42.08
Debt to Equity (x) info -----1.01-1.02-1.02

Profitability

View Detailed Peer Comparison

ROCE

--

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
-2.08
-45.82
-176.12
-36.29
Peer Median
--
11.89
12.20
15.46
15.21
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROE

--

--

Profit after tax / Average Net worth * 100

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
--
--
--
--
Peer Median
10.86
13.43
10.09
12.97
9.89
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
ROA

-2.49

Lower than Peers by 9.23

Profit after tax / Average Total assets * 100

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-2.49
-1.99
-42.08
-165.20
-35.22
Peer Median
6.74
7.03
5.74
5.99
5.28
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
--
--
--
--
Peer Median
8.86
10.49
8.84
10.39
9.44
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Growth

View Detailed Peer Comparison

EBIT Growth

-25.00

Lower than Peers by 42.24

Year on year growth in operating profit (EBIT)

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-25.00
96.07
76.01
-369.24
66.15
Peer Median
17.24
18.27
3.48
28.31
22.09
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Net Profit Growth

-25.00

Lower than Peers by 41.85

Year on year growth in profit after tax

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-25.00
95.93
76.01
-369.16
66.27
Peer Median
16.85
27.20
-8.07
24.50
9.35
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EPS Growth

-25.00

Lower than Peers by 35.60

Year on year growth in earnings per share

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-25.00
95.98
76.01
-369.16
66.27
Peer Median
10.60
16.28
-5.54
24.50
5.26
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Book Value Growth

--

--

Year on year growth in book value per share

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
-0.04
-0.90
-3.90
-0.84
Peer Median
--
--
--
--
--
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Solvency

View Detailed Peer Comparison

Debt to Equity

-1.01

Lower than Peers by 1.06

Total debt / Net worth

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-1.01
-1.02
-1.02
-1.02
-1.02
Peer Median
0.04
0.15
0.26
0.29
0.29
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Current Ratio

0.17

Lower than Peers by 1.55

Current Assets / Current Liabilities and Provisions

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
0.17
0.18
2.69
1.68
5.54
Peer Median
1.72
1.89
1.74
1.79
1.68
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Quick Ratio

0.17

Lower than Peers by 1.01

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
0.17
0.18
2.69
1.68
5.54
Peer Median
1.17
1.64
1.32
1.39
1.25
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
-28.38
-3,332.29
--
-5,822.27
Peer Median
7.86
15.38
12.04
13.34
10.92
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Operating Efficiency

View Detailed Peer Comparison

Asset Turnover

--

--

Sales / Average Total Assets

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
--
--
--
--
Peer Median
0.67
0.61
0.51
0.69
0.73
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Valuation

View Detailed Peer Comparison

Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
--
--
--
--
Peer Median
39.90
60.11
64.03
23.97
31.85
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Price / Book Value

-0.88

Lower than Peers by 5.12

Current share price divided by book value per share in the latest financial year

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-0.88
--
--
--
--
Peer Median
4.23
3.92
3.87
2.47
2.93
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
--
--
--
--
--
Peer Median
0.10
0.56
0.61
0.79
0.56
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
EV/EBITDA

-4,081.20

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
-4,081.20
-7,999.21
-314.50
-75.25
-348.60
Peer Median
--
25.94
28.78
21.97
23.55
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
Market Cap

9

Lower than Peers by 7,603

Current Share price multiplied by latest total number of shares outstanding

Company Name
TTM
Mar-21
Mar-20
Mar-19
Mar-18
Mesco Pharmaceuticals
9
--
--
--
--
Peer Median
7,613
13,501
14,139
8,549
10,579
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...